Gayet-Ageron Angèle, Combescure Christophe, Lautenschlager Stephan, Ninet Béatrice, Perneger Thomas V
Division of Clinical Epidemiology, Department of Health and Community Medicine, University of Geneva and University Hospitals of Geneva, Geneva, Switzerland
Division of Clinical Epidemiology, Department of Health and Community Medicine, University of Geneva and University Hospitals of Geneva, Geneva, Switzerland.
J Clin Microbiol. 2015 Nov;53(11):3522-9. doi: 10.1128/JCM.01619-15. Epub 2015 Aug 26.
Treponema pallidum PCR (Tp-PCR) testing now is recommended as a valid tool for the diagnosis of primary or secondary syphilis. The objectives were to systematically review and determine the optimal specific target gene to be used for Tp-PCR. Comparisons of the performance of the two main targets are tpp47 and polA genes were done using meta-analysis. Three electronic bibliographic databases, representing abstract books from five conferences specialized in infectious diseases from January 1990 to March 2015, were searched. Search keywords included ("syphilis" OR "Treponema pallidum" OR "neurosyphilis") AND ("PCR" OR "PCR" OR "molecular amplification"). We included diagnostic studies assessing the performance of Tp-PCR targeting tpp47 (tpp47-Tp-PCR) or the polA gene (polA-Tp-PCR) in ulcers from early syphilis. All studies were assessed against quality criteria using the QUADAS-2 tool. Of 37 studies identified, 62.2% were judged at low risk of bias or applicability. Most used the U.S. Centers for Disease Control and Prevention (CDC) case definitions for primary or secondary (early) syphilis (89.2%; n = 33); 15 (40.5%) used darkfield microscopy (DFM). We did not find differences in sensitivity and specificity between the two Tp-PCR methods in the subgroup of studies using adequate reference tests. Among studies using DFM as the reference test, sensitivities were 79.8% (95% confidence intervals [CI], 72.7 to 85.4%) and 71.4% (46.0 to 88.0%) for tpp47-Tp-PCR and polA-Tp-PCR (P = 0.217), respectively; respective specificities were 95.3% (93.5 to 96.6%) and 93.7% (91.8 to 95.2%) (P = 0.304). Our findings suggest that the two Tp-PCR methods have similar accuracy and could be used interchangeably.
梅毒螺旋体PCR(Tp-PCR)检测目前被推荐作为诊断一期或二期梅毒的有效工具。目的是系统评价并确定用于Tp-PCR的最佳特异性靶基因。采用荟萃分析对两个主要靶基因tpp47和polA基因的性能进行比较。检索了三个电子文献数据库,这些数据库涵盖了1990年1月至2015年3月期间五个传染病专业会议的摘要书籍。检索关键词包括(“梅毒”或“梅毒螺旋体”或“神经梅毒”)以及(“PCR”或“聚合酶链反应”或“分子扩增”)。我们纳入了评估针对tpp47的Tp-PCR(tpp47-Tp-PCR)或polA基因(polA-Tp-PCR)在早期梅毒溃疡中性能的诊断研究。所有研究均使用QUADAS-2工具根据质量标准进行评估。在识别出的37项研究中,62.2%被判定为偏倚或适用性风险较低。大多数研究采用美国疾病控制与预防中心(CDC)的一期或二期(早期)梅毒病例定义(89.2%;n = 33);15项研究(40.5%)采用暗视野显微镜检查(DFM)。在使用充分参考检测的研究亚组中,我们未发现两种Tp-PCR方法在敏感性和特异性方面存在差异。在以DFM作为参考检测的研究中,tpp47-Tp-PCR和polA-Tp-PCR的敏感性分别为79.8%(95%置信区间[CI],72.7至85.4%)和71.4%(46.0至88.0%)(P = 0.217);各自的特异性分别为95.3%(93.5至96.6%)和93.7%(91.8至95.2%)(P = 0.304)。我们的研究结果表明,两种Tp-PCR方法具有相似的准确性,可以互换使用。